Julie Hambleton, Director at SpringWorks Therapeutics, Inc. (SWTX), sold 1,106 shares at $31.50 ($35K) on 2023-03-15, disclosed to the SEC on 2023-03-16.
Open-market sale of $35k SWTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SWTX | SELL | 2024-06-05 | $302K | — | Filing → |
| SWTX | SELL | 2023-07-21 | $142K | — | Filing → |
| SWTX | SELL | 2023-06-22 | $129K | — | Filing → |